Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Multiple sclerosis and sexual dysfunction.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Trial watch: Chemotherapy with immunogenic cell death inducers.
A touch of MS: Therapeutic mislabeling.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.

Pages